Currently, MR-guided focused ultrasound (MRgFUS) has been approved in the US and abroad for the commercial treatment of uterine fibroids.  It has also been approved in Europe for the commercial treatment of pain due to metastatic bone cancer. Please use the links provided below for a list of commercial treatment sites for the following conditions:

• Uterine fibroids
• Pain from bone cancer

In addition to commercial treatment sites, there are a number of sites participating in clinical trials for new or enhanced clinical application of MRgFUS. Please use the links provided below for information about clinical trial sites that are investigating the use of MRgFUS for the following conditions:

• Enhanced treatment of uterine fibroids using expanded parameters
• Pain from bone cancer
• Low back pain
• Essential tremor
• Brain cancer
• Breast cancer